Gilead Sciences
GILD
#94
Rank
NZ$305.89 B
Marketcap
NZ$246.40
Share price
-0.56%
Change (1 day)
28.75%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): NZ$11.23

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is NZ$11.13. In 2024 the company made an earnings per share (EPS) of NZ$0.65 a decrease over its 2023 EPS that were of NZ$7.76.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$11.231631.28%
2024NZ$0.65-91.65%
2023NZ$7.7623.98%
2022NZ$6.26-25.86%
2021NZ$8.454850%
2020NZ$0.17-97.64%
2019NZ$7.240.9%
2018NZ$7.1718.71%
2017NZ$6.04-64.88%
2016NZ$17.20-18.45%
2015NZ$21.0955.28%
2014NZ$13.58296.02%
2013NZ$3.4317.89%
2012NZ$2.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.00 70.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.32-79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$4.08-63.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$39.28 253.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.45 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.75 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$7.63-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$24.45 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.47 12.07%๐Ÿ‡บ๐Ÿ‡ธ USA